| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/19/2005 | CN1568180A Pharmaceutical formulations for the controlled release of 4-amino-6, 7-dimethoxy-2-(5-methanesulfonamido-1, 2, 3, 4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)-quinazoline |
| 01/19/2005 | CN1568179A Powder processing with pressurized gaseous fluids |
| 01/19/2005 | CN1568178A Injectable composition of paclitaxel |
| 01/19/2005 | CN1568177A Anti-microbial composition comprising a metal ion chelating agent |
| 01/19/2005 | CN1566404A Lung cavity aeration liquid and its preparation method |
| 01/19/2005 | CN1566160A Mu Shen polysaccharide and its immunoregulation and anticancer function |
| 01/19/2005 | CN1566145A Polyvalent pneumococcal polysaccharide combination vaccine |
| 01/19/2005 | CN1566140A Wan fritillaria extract, preparation method and uses thereof |
| 01/19/2005 | CN1566137A Production process for platycodin |
| 01/19/2005 | CN1566136A Pasqueflower notoginsenosides and extraction method, medicinal uses and pharmaceutical preparation thereof |
| 01/19/2005 | CN1566132A Schizophrenia susceptible gene----KPNB3 gene and uses thereof |
| 01/19/2005 | CN1566131A Small interference RNA molecule SiRNA capable of attacking human hepatitis B virus and application thereof |
| 01/19/2005 | CN1566130A Nucleoside analogue lipid derivative and salt thereof |
| 01/19/2005 | CN1566129A 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| 01/19/2005 | CN1566128A Sugar charcoal glycoside isoflavone compound containing alkane amine group and alkoxy substitution, process and uses thereof |
| 01/19/2005 | CN1566127A Novel flavonoids |
| 01/19/2005 | CN1566126A Novel natural drug effective region |
| 01/19/2005 | CN1566125A Scutellarin complex salt and preparing method for preparation thereof |
| 01/19/2005 | CN1566124A Cornel extract and use thereof |
| 01/19/2005 | CN1566118A Antiviral activity possessed compound and preparation method thereof |
| 01/19/2005 | CN1566109A Aldose reductase inhibitor, preparation method and use thereof |
| 01/19/2005 | CN1566108A Red clover total flavone high content extract, preparation and application in pharmaceutical combination thereof |
| 01/19/2005 | CN1566107A Extraction method of baicalin element and application in antiinflammation and ease pain thereof |
| 01/19/2005 | CN1566103A Moguisteine crystallographic form |
| 01/19/2005 | CN1566100A Aporphine and ketone group aporphine compound and medicinal use thereof |
| 01/19/2005 | CN1566098A Isoquinoline compound, preparation method and application of salt thereof |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1566094A Antiviral activity possessed compound |
| 01/19/2005 | CN1566092A Indene ketone diindyl class compound, preparation method and medical use thereof |
| 01/19/2005 | CN1566091A Molindone derivatives and use for preparing antineoplastic medicine thereof |
| 01/19/2005 | CN1566086A Amino acid calcium chelate, preparation and application thereof |
| 01/19/2005 | CN1566065A Alpha position heteroatom substituted gamma aryl ketobutyric acid derivative, process, pharmaceutical combination and uses thereof |
| 01/19/2005 | CN1566061A Novel natural drug effective region of rabdosiaexcisa total diterpene |
| 01/19/2005 | CN1566054A Resveratrol oligo cattail compounds, its manufacturing process, pharmaceutical combination and uses thereof |
| 01/19/2005 | CN1565541A Osteodynia alleviating and wind dispelling liniment |
| 01/19/2005 | CN1565474A Biochemical nucleic acid fulvic acid oral liquid production method |
| 01/19/2005 | CN1565473A Water soluble nightshade extract, its preparation method and pharmaceutical compositions |
| 01/19/2005 | CN1565472A Breviscapine slow release microsphere medicine formulation |
| 01/19/2005 | CN1565471A Breviscapine drop pill |
| 01/19/2005 | CN1565470A Antiparasitic medicine long-acting injection containing |
| 01/19/2005 | CN1565469A Cornel extract oral medicine compositions low irritative to gastrointestinal tract and its preparation |
| 01/19/2005 | CN1565468A S.japonica (Sw.) Ohwi flavone glucoside capsule and its production method |
| 01/19/2005 | CN1565467A Use of cornel and its extract in preparation alpha-glucosidase inhibitor medicine |
| 01/19/2005 | CN1565466A S.japonica (Sw.) Ohwi flavone glucoside injection and its preparing process |
| 01/19/2005 | CN1565465A Injection preparation containing breviscapine active component and its preparation method |
| 01/19/2005 | CN1565464A Haw effective part and its extracting method and uses |
| 01/19/2005 | CN1565463A Hepatitis B therapeutic medicine |
| 01/19/2005 | CN1565462A Itch relieving detumescent medicine |
| 01/19/2005 | CN1565461A Use of stachyose in preparing drug for diabetes and its preparation method |
| 01/19/2005 | CN1565460A Acne therapeutic chemical tincture and its preparation method |
| 01/19/2005 | CN1565459A Dermatopathy therapeutic medicine compositions and its preparation method |
| 01/19/2005 | CN1565458A Tomatine preparation for prevention and cure of tissue and organ fibrosis |
| 01/19/2005 | CN1565457A Beta- lactamase suppressing antibacterial compound drugs |
| 01/19/2005 | CN1565456A Cefepime compound antibacterial drugs |
| 01/19/2005 | CN1565455A Antibiotics compositions for curing broad spectrum beta-lactamase bacteria infection |
| 01/19/2005 | CN1565454A Solid preparation for refreshment and its preparation method |
| 01/19/2005 | CN1565453A 6-amino-ª‡(R)-hydroxyl-9H-purin-9-ethyl butyrate immunological suppression effect |
| 01/19/2005 | CN1565452A Neurofender, the novel formulation of preventing and delaying aging and death of human cerebral neurocyte |
| 01/19/2005 | CN1565451A Naloxone Hydrochloride nose powder preparation |
| 01/19/2005 | CN1565450A Naloxone Hydrochloride Injection and its preparation method |
| 01/19/2005 | CN1565449A Pyrroloquinoline containing composition for enriching zinc and reducing plumbum |
| 01/19/2005 | CN1565448A Nitrendipine dispersion tablet and method for making same |
| 01/19/2005 | CN1565447A Drug for prevention and cure of bacterial and viral infection , atypical pneumonia |
| 01/19/2005 | CN1565446A Freeze-drying fluconazole injection and its preparation method |
| 01/19/2005 | CN1565445A N-phenylpyrazoles drug containing long-acting injection for animals |
| 01/19/2005 | CN1565444A Ramatroban glue pill and its preparation method |
| 01/19/2005 | CN1565443A Daphnetin cyclodextrin clathrate compound, formulation and its preparation method |
| 01/19/2005 | CN1565442A Use of racemoid nor-poon essence A in preparation of AIDS drug |
| 01/19/2005 | CN1565441A Use of levobutylphthalide in prevention and cure of dementia |
| 01/19/2005 | CN1565440A Silymarin Methylglucamine clathrate compound and its preparation method |
| 01/19/2005 | CN1565439A Osteoporosis relieving health food |
| 01/19/2005 | CN1565438A Use of 5-hydroxymethyl furfural in preparation of drug for nerve system |
| 01/19/2005 | CN1565437A Verapamil hydrochloric acid drop pill and its preparation method |
| 01/19/2005 | CN1565436A Retinoic acid release control nanomicrosphere and its preparation method |
| 01/19/2005 | CN1565435A Nasal cavity nursing solution |
| 01/19/2005 | CN1565434A Orally administered Modafinil medicine compostion |
| 01/19/2005 | CN1565433A Hypocrellin water-soluble nanogranule and its uses |
| 01/19/2005 | CN1565432A Use of gossypol and its derivative in preparation of drug for leukemia / bone marrow cancer |
| 01/19/2005 | CN1565431A 3, 4-dihydroxylbenzaldehyde pharmaceutical use |
| 01/19/2005 | CN1565430A Allicin cyclodextrin clathrate compound, formulation and its preparation method |
| 01/19/2005 | CN1565427A Gastric 5-fluorouracil double slow release tablet of float and stay type for curing gastric cancer |
| 01/19/2005 | CN1565422A AIDS drug didanosine granula composition and its preparation method |
| 01/19/2005 | CN1185352C Compounds having glucuronic acid derivatives and glucosamine derivatives in structure, process for producing same and utilization thereof |
| 01/19/2005 | CN1185344C Protein for blocking platelet adhesion |
| 01/19/2005 | CN1185253C Neoglycoproteins |
| 01/19/2005 | CN1185250C Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/19/2005 | CN1185249C Non-aromatic estrogenic steroids with hydrocarbon substituent in position 11 |
| 01/19/2005 | CN1185247C Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates |
| 01/19/2005 | CN1185243C Tetrahydroxydiphenylethylene glycosides compounds for preventing and curing angiocardiopathy and cerebrovascular diseases |
| 01/19/2005 | CN1185233C Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/19/2005 | CN1185232C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 01/19/2005 | CN1185231C Meadowrueleaf corydalis general alkaloid and its prepn and application |
| 01/19/2005 | CN1185230C N-substituted carbamoyloxyalkyl-azolium derivs. |
| 01/19/2005 | CN1185229C 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 01/19/2005 | CN1185228C Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 01/19/2005 | CN1185227C Novel compounds |
| 01/19/2005 | CN1185226C Intermediate for preparing benzothiophene amide derivate |
| 01/19/2005 | CN1185223C Novel Compounds and methods for synthesis and therapy |
| 01/19/2005 | CN1185220C Para-amino substituted phenylamide glucokinase activators |
| 01/19/2005 | CN1185219C Trans olefinic glucokinase activators |